CYP2E1 and alcoholic fatty liver disease: Moreover, recent studies showed that chemical inhibition of CYP2E1 and other alcohol metabolizing enzymes reduces alcoholic steatohepatitis by decreasing triglyceride accumulation and proinflammatory cytokine levels in liver [44].